Zomedica Announces Preliminary 2023 Revenue; Provides Revenu

Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")

Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")

torontotelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from torontotelegraph.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Michigan , United States , Ann Arbor , American , Larry Heaton , Equity Research Analyst Coverage , Zomedica Corp , New York Stock Exchange , Investor Relations Zomedica Inc , York Stock Exchange , Therapeutic Device , Therapeutic Devices , Cash Equivalents , Available For Sale Securities , Zomedica Chief Executive Officer , Special Virtual Only Meeting , Special Meeting , Broader Range , Stock Indices Inclusion , Proxy Circular , Investor Relations , Zomedica Corporate Website , Business Update Conference Call , Zomedica Business Update , Statement Regarding Forward Looking Statements ,